{"version":"1.0","provider_name":"Innovations- und Gr\u00fcnderzentrum Biotechnologie IZB","provider_url":"https:\/\/www.izb-online.de\/en\/","title":"SIRION Biotech\u2019s technology supports clinical projects.","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"HrPKDs1qDc\"><a href=\"https:\/\/www.izb-online.de\/en\/neue-partner-in-london-und-san-francisco\/\">SIRION Biotech\u2019s technology supports clinical projects.<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/www.izb-online.de\/en\/neue-partner-in-london-und-san-francisco\/embed\/#?secret=HrPKDs1qDc\" width=\"600\" height=\"338\" title=\"&#8220;SIRION Biotech\u2019s technology supports clinical projects.&#8221; &#8212; Innovations- und Gr\u00fcnderzentrum Biotechnologie IZB\" data-secret=\"HrPKDs1qDc\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script>\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/www.izb-online.de\/wp-includes\/js\/wp-embed.min.js\n<\/script>\n","thumbnail_url":"https:\/\/www.izb-online.de\/wp-content\/uploads\/2020\/04\/IZB-News_Sirion-neue-Partner_San-Francisco_beitragsbild-quer_20191.jpg","thumbnail_width":400,"thumbnail_height":255,"description":"Our last issue\u2019s headline about SIRION Biotech was labeled \u201cto Paris and Boston\u201d, as we reported on the company\u2019s new branches in two of the Western World\u2019s biggest gene therapy hotspots. Now SIRION Biotech has announced new global development and licensing partnerships with two major gene-therapy players, Orchard Therapeutics in London and Denali Therapeutics in San Francisco. Orchard Therapeutics developed Strim\u00advelis, the first therapy for ADA-SCID, formerly known as 'bubble-boy disease', that was approved in Europe."}